A substituted quinoline compound and its pharmaceutical compositions and applications are provided, such as compounds as shown by the quinoline compounds (I), or their crystalline, pharmaceutically acceptable salts, hydrates, or solvent compounds. The compound can be used as a hepatitis C virus inhibitor, and has a better inhibitory activity of hepatitis C virus protein NS3/4A. It has better pharmacodynamic / pharmacokinetic properties, good applicability and high safety. It can be used in the preparation of hepatitis C virus infection drugs, and has a good market development prospects.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请,说明书已公开。
【技术保护点】
PCT国内申请,权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.08....
【专利技术属性】
技术研发人员:王义汉,金剑,
申请(专利权)人:深圳市塔吉瑞生物医药有限公司,
类型:发明
国别省市:广东,44
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。